Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Journal of Zhejiang University. Science. B ; (12): 253-263, 2019.
Article in English | WPRIM | ID: wpr-1010455

ABSTRACT

Valproic acid (VPA), an agent that is used to treat epileptic seizures, can cause spatial memory impairment in adults and children. This effect is thought to be due to the ability of VPA to inhibit neurogenesis in the hippocampus, which is required for learning. We have previously used an animal model to show that VPA significantly impairs hippocampal-spatial working memory and inhibits neuronal generation in the sub-granular zone of the dentate gyrus. As there are patient reports of improvements in memory after discontinuing VPA treatment, the present study investigated the recovery of both spatial memory and hippocampal neurogenesis at two time points after withdrawal of VPA. Male Wistar rats were given intraperitoneal injections of 0.9% normal saline or VPA (300 mg/kg) twice a day for 10 d. At 1, 30, or 45 d after the drug treatment, the novel object location (NOL) test was used to examine spatial memory; hippocampal cell division was counted using Ki67 immunohistochemistry, and levels of brain-derived neurotrophic factor (BDNF) and Notch1 were measured using western immunoblotting. Spatial working memory was impaired 1 and 30 d after the final administration, but was restored to control levels by 45 d. Cell proliferation had increased to control levels at 30 and 45 d. Both markers of neurogenesis (BDNF and Notch1 levels) had returned to control levels at 45 d. These results demonstrate that memory recovery occurs over a period of six weeks after discontinuing VPA treatment and is preceded by a return of hippocampal neurogenesis to control levels.


Subject(s)
Animals , Male , Rats , Brain-Derived Neurotrophic Factor/metabolism , Cell Proliferation , Cognition/drug effects , Dentate Gyrus/drug effects , Enzyme Inhibitors/pharmacology , Hippocampus/metabolism , Immunohistochemistry , Memory Disorders/therapy , Memory, Short-Term/drug effects , Neurogenesis/drug effects , Neurons/metabolism , Rats, Wistar , Receptor, Notch1/metabolism , Spatial Memory/drug effects , Valproic Acid/pharmacology
2.
in English | IMSEAR | ID: sea-133239

ABSTRACT

Background : Hemangiopericytoma is the one type of soft tissue sarcomas. This is very rare and uncommon type of tumor. So The surgeon and another doctor should be reminded  to  keep  in  mind.Objective : To  report  a  case  of metastastic hemangiopericytoma metastasized from  the  right  inguinal  region  to  the  liver  in  12  years.Design : Retrospective study by review of  170,000 cases  medical records and pathological study.Setting : Department of Pathology, Faculty of Medicine, Khon Kaen University, Khon   Kaen province.Result : We reported a case of a 68-year old female who was initially diagnosed with hemangioperocytoma of soft tissue at her right  inguinal  region  which was surgically excised. However twelve years later in July 2003, a tumor mass was discovered in her liver which the histology  is  characterized  mostly similar to the earlier right inguinal  tumor. Thus we diagnosed the patient  with metastatic hemangiopericytoma in the liver. Two years after the removal of the tumor, she has no  evidence of the other metastasis or recurrence. Twenty two cases of extracranial metastasis of hemangiopericytomatous meningioma  to  the  liver, lung, kidney, and stomach have been reported in the literature, but hepatic resections of this metastasizing tumor have been very rare.Conclusion : We  reported  the  very  rare  case  of  histopathologically – proven  metastasized  hemangiopericytoma  from  the  right  inguinal  region  to  the  liver.Key words : Hemangiopericytoma ; Hepatic metastasis ; Spindle cell tumor ; Liver tumor. liver 

SELECTION OF CITATIONS
SEARCH DETAIL